• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model
2009 NIHR Health Technology Assessment programme Clinical and cost effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for the treatment of pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation
2009 The Swedish Council on Health Technology Assessment (SBU) [Transcranial magnetic stimulation in treating depression]
2009 The Swedish Council on Health Technology Assessment (SBU) [Leukocytapheresis in inflammatory bowel disease (primarily ulcerative colitis)]
2009 Agency for Healthcare Research and Quality (AHRQ) Use of Bayesian techniques in randomized clinical trials: a CMS case study
2009 Agency for Healthcare Research and Quality (AHRQ) Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009 Agency for Healthcare Research and Quality (AHRQ) Complementary and alternative medicine in back pain utilization report
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The relevance of the neonatal urine screening for inborn errors of metabolism performed in Quebec]
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Systematic review of the effects of home telemonitoring in the context of diabetes, pulmonary diseases and cardiovascular diseases]
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [State of knowledge: Telemedicine and radiation oncology: state of the evidence]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents in the secondary prevention of vascular events in adults with cerebrovascular disease: clinical and cost-effectiveness analyses
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Erythropoiesis-stimulating agents for anemia of cancer or of chemotherapy
2009 Finnish Office for Health Care Technology Assessment (Finohta) [Green laser treatment of hyperplasia of the prostate]
2009 Finnish Office for Health Care Technology Assessment (Finohta) [Long term sensors for measuring blood sugar]
2009 Haute Autorite de sante (HAS) [Dental prostheses with ceramic and/or milled cores (full assessment)]
2009 Institute of Applied Health Sciences (IAHS) Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high risk surgical patients
2009 Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and nonpharmaceutical interventions for Alzheimer’s disease, a rapid assessment
2009 Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009 Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: rapid assessment
2009 Belgian Health Care Knowledge Centre (KCE) Robot-assisted surgery: health technology assessment
2009 Belgian Health Care Knowledge Centre (KCE) Use of point-of care devices in patients with oral anticoagulation: a health technology assessment
2009 Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009 Medical Services Advisory Committee (MSAC) Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2009 Medical Services Advisory Committee (MSAC) Automation-assisted and liquid-based cytology for cervical cancer screening
2009 NIHR Health Technology Assessment programme Breastfeeding promotion for infants in neonatal units: a systematic review and economic analysis
2009 NIHR Health Technology Assessment programme Are adverse effects incorporated in economic models? An initial review of current practice
2009 NIHR Health Technology Assessment programme Assessment of the use of surrogate outcomes in model-based cost effectiveness analyses within UK health technology assessment reports
2009 NIHR Health Technology Assessment programme Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional hemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme The effects of biofeedback for the treatment of essential hypertension: a systematic review
2009 NIHR Health Technology Assessment programme The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis
2009 NIHR Health Technology Assessment programme Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Endovascular stents for abdominal aortic aneurysms
2009 NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Infliximab for the treatment of adults with psoriasis
2009 NIHR Health Technology Assessment programme Lapatinib for the treatment of HER2-overexpressing breast cancer
2009 NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2009 NIHR Health Technology Assessment programme Rimonabant for the treatment of overweight and obese people
2009 NIHR Health Technology Assessment programme Infliximab for the treatment of ulcerative colitis
2009 The Netherlands Organisation for Health Research and Development (ZonMw) [Prenatal diagnosis: MLPA or karyotyping]
2009 Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness of ozone therapies]
2009 The Swedish Council on Health Technology Assessment (SBU) [Dopaminergic agents in treating restless legs syndrome]
2009 The Swedish Council on Health Technology Assessment (SBU) [Therapeutic hypothermia following perinatal asphyxia]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Systematic review of the multidisciplinary combined treatment in peritoneal neoplasms. Radical surgical citoreduction + intraperitoneal chemotherapy +/- hyperthermia (Sugarbaker's technique)
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Clinical practice guideline on eating disorders
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Medical and health economic assessment of radiosurgery for the treatment of brain metastasis]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Behavioural and skill-based early interventions in children with autism spectrum disorders]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness and cost-efficiency of phosphate binders in hemodialysis]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessments tools for risk prediction of cardiovascular diseases]
2009 Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009 Institute of Health Economics (IHE) Effectiveness of organizational interventions for the prevention of stress in the workplace
2009 Belgian Health Care Knowledge Centre (KCE) Fatigue Syndrome: diagnosis, treatment and organisation of care
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Autologous chondrocyte implantation
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Development of decision-aid: HPV-patient information]
2009 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Isokinetic exercise machine
2009 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Fibroscan
2009 Medical Services Advisory Committee (MSAC) Computer-navigated total knee arthroplasty
2009 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of machine perfusion systems and cold static storage of donated kidneys
2009 NIHR Health Technology Assessment programme Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Zanamivir, oseltamivir and amantadine for the treatment of influenza (an update review of existing guidance)
2009 NIHR Health Technology Assessment programme Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
2009 NIHR Health Technology Assessment programme Enhanced external counterpulsation for stable angina or heart failure: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Non-occupational post-exposure prophylaxis for HIV
2009 NIHR Health Technology Assessment programme The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal
2009 NIHR Health Technology Assessment programme A systematic review of presumed consent systems for deceased organ donation
2009 VA Technology Assessment Program (VATAP) Visual problems in traumatic brain injury
2009 VA Technology Assessment Program (VATAP) Complementary and alternative therapies for post-traumatic stress disorder
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Screening mammography for woman aged 40-49: update]
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparative analysis of bedpan processing equipment
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Comparative analysis of thermal disinfection with a washer-disinfector and pasteurization: anaesthesia and respiratory devices]
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Evaluation of ethylene oxide sterilant alternatives: plasma and ozone]
2009 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009 Adelaide Health Technology Assessment (AHTA) Molecular testing for myeloproliferative disease
2009 Adelaide Health Technology Assessment (AHTA) Cryotherapy for recurrent prostate cancer and renal cancer
2009 Adelaide Health Technology Assessment (AHTA) The management of acute/subacute soft tissue injuries to the low back: Evidence update and recommendations for clinical practice
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Labour care in healthy women.Study of variability and systematic review]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to parents about neonatal screening for inborn errors of metabolism: assessment of current situation and establishment evidence-based information standards]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lung cancer screening]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Clinical practice guideline on major depression in childhood and adolescence
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Anti-TNF-a drugs for refractory inflammatory bowel disease: clinical- and cost-effectiveness analyses
2009 Institute for Clinical and Economic Review (ICER) Coronary computed tomographic angiography for detection of coronary artery disease
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Anticonvulsants, serotonin- norepinephrine reuptake inhibitors, and tricyclic antidepressants in management of neuropathic pain: a meta-analysis and economic evaluation
2009 NIHR Health Technology Assessment programme Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional hemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis
2009 NIHR Health Technology Assessment programme Surgical procedures and non-surgical devices for the management of non-apnoeic snoring: a systematic review of clinical effects and associated treatment costs
2009 NIHR Health Technology Assessment programme Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis
2009 NIHR Health Technology Assessment programme Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review
2009 NIHR Health Technology Assessment programme The harmful health effects of recreational ecstasy: a systematic review of observational evidence
2009 NIHR Health Technology Assessment programme Systematic review of the clinical effectiveness and cost-effectiveness of oesophageal Doppler monitoring in critically ill and high risk surgical patients
2009 NIHR Health Technology Assessment programme The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports
2009 NIHR Health Technology Assessment programme Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS) - a randomised controlled trial
2009 NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2009 NIHR Health Technology Assessment programme Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
2009 Penn Medicine Center for Evidence-based Practice (CEP) Evidence-based design for hospital noise reduction
2009 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The effect of fatigue on surgeon performance
2009 NIHR Health Technology Assessment programme Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods